Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.

A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cuta...

Full description

Bibliographic Details
Main Authors: Shams Rahman, Dana E Rollison, Christine M Pierce Campbell, Tim Waterboer, Angelika Michel, Michael Pawlita, Luisa L Villa, Eduardo Lazcano Ponce, Wei Wang, Amy R Borenstein, Anna R Giuliano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5125700?pdf=render
_version_ 1811273269543698432
author Shams Rahman
Dana E Rollison
Christine M Pierce Campbell
Tim Waterboer
Angelika Michel
Michael Pawlita
Luisa L Villa
Eduardo Lazcano Ponce
Wei Wang
Amy R Borenstein
Anna R Giuliano
author_facet Shams Rahman
Dana E Rollison
Christine M Pierce Campbell
Tim Waterboer
Angelika Michel
Michael Pawlita
Luisa L Villa
Eduardo Lazcano Ponce
Wei Wang
Amy R Borenstein
Anna R Giuliano
author_sort Shams Rahman
collection DOAJ
description A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cutaneous HPV seropositivity and development of external genital lesions (EGLs) in men.To examine the association between seropositivity to cutaneous HPV types and the risk of subsequent development of EGLs.A nested case-control study including 163 incident EGL cases and 352 EGL-free controls in the HPV Infection in Men (HIM) Study cohort was conducted. Cases were ascertained at each of up to 10 biannual clinical visits and verified through biopsy and pathological diagnoses. EGLs were categorized as condyloma, suggestive of condyloma, penile intraepithelial neoplasia (PeIN), and other EGLs. Archived serum specimens collected at baseline were tested for antibodies against 14 cutaneous HPV types (β types (5, 8, 12, 14, 17, 22, 23, 24, 38, and 47), α type 27, γ type 4, μ type 1, and ν type 41) using a GST L1-based multiplex serology assay. Socio-demographic and sexual behavior data were collected through a questionnaire. Using logistic regression, adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated.Overall, seropositivity to ≥1 cutaneous HPV type (any-HPV) and ≥1 β types (any-β) was 58.3% and 37.5% among other EGL cases, 71.6% and 46.8% among condyloma, 66.8% and 50.0% among PeIN, and 71.9% and 38.4% among controls, respectively. Type-specific seropositivity was most common for ɤ-HPV 4, μ-HPV 1, and β-HPV 8. No statistically significant association was observed between any-HPV, any-β, and type-specific HPV seropositivity and subsequent development of EGLs across all pathological diagnoses.Overall, seropositivity to cutaneous HPV was common among men; however, it appears that cutaneous HPV is not associated with the development of genital lesions in men.
first_indexed 2024-04-12T22:56:07Z
format Article
id doaj.art-bd1149514c5d4d6980e80d576b8521da
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T22:56:07Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-bd1149514c5d4d6980e80d576b8521da2022-12-22T03:13:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011111e016717410.1371/journal.pone.0167174Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.Shams RahmanDana E RollisonChristine M Pierce CampbellTim WaterboerAngelika MichelMichael PawlitaLuisa L VillaEduardo Lazcano PonceWei WangAmy R BorensteinAnna R GiulianoA variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cutaneous HPV seropositivity and development of external genital lesions (EGLs) in men.To examine the association between seropositivity to cutaneous HPV types and the risk of subsequent development of EGLs.A nested case-control study including 163 incident EGL cases and 352 EGL-free controls in the HPV Infection in Men (HIM) Study cohort was conducted. Cases were ascertained at each of up to 10 biannual clinical visits and verified through biopsy and pathological diagnoses. EGLs were categorized as condyloma, suggestive of condyloma, penile intraepithelial neoplasia (PeIN), and other EGLs. Archived serum specimens collected at baseline were tested for antibodies against 14 cutaneous HPV types (β types (5, 8, 12, 14, 17, 22, 23, 24, 38, and 47), α type 27, γ type 4, μ type 1, and ν type 41) using a GST L1-based multiplex serology assay. Socio-demographic and sexual behavior data were collected through a questionnaire. Using logistic regression, adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated.Overall, seropositivity to ≥1 cutaneous HPV type (any-HPV) and ≥1 β types (any-β) was 58.3% and 37.5% among other EGL cases, 71.6% and 46.8% among condyloma, 66.8% and 50.0% among PeIN, and 71.9% and 38.4% among controls, respectively. Type-specific seropositivity was most common for ɤ-HPV 4, μ-HPV 1, and β-HPV 8. No statistically significant association was observed between any-HPV, any-β, and type-specific HPV seropositivity and subsequent development of EGLs across all pathological diagnoses.Overall, seropositivity to cutaneous HPV was common among men; however, it appears that cutaneous HPV is not associated with the development of genital lesions in men.http://europepmc.org/articles/PMC5125700?pdf=render
spellingShingle Shams Rahman
Dana E Rollison
Christine M Pierce Campbell
Tim Waterboer
Angelika Michel
Michael Pawlita
Luisa L Villa
Eduardo Lazcano Ponce
Wei Wang
Amy R Borenstein
Anna R Giuliano
Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.
PLoS ONE
title Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.
title_full Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.
title_fullStr Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.
title_full_unstemmed Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.
title_short Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study.
title_sort seroprevalence of cutaneous human papillomaviruses and the risk of external genital lesions in men a nested case control study
url http://europepmc.org/articles/PMC5125700?pdf=render
work_keys_str_mv AT shamsrahman seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT danaerollison seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT christinempiercecampbell seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT timwaterboer seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT angelikamichel seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT michaelpawlita seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT luisalvilla seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT eduardolazcanoponce seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT weiwang seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT amyrborenstein seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT annargiuliano seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy